Risperidone for Individuals With Refractory Schizophrenia

Clinical Medicine Insights: Therapeutics - New Zealand
doi 10.4137/cmt.s3567
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Risperidone Versus Placebo for Schizophrenia

Cochrane Database of Systematic Reviews
2016English

Reasons for Smoking Among Individuals With Schizophrenia

Schizophrenia Research
PsychiatryMental HealthBiological Psychiatry
2010English

Implementation of a Family Intervention for Individuals With Schizophrenia

Journal of General Internal Medicine
Internal Medicine
2010English

Rechallenging With Clozapine Following Neutropenia: Treatment Options for Refractory Schizophrenia

American Journal of Psychiatry
PsychiatryMental Health
2008English

Indirect Self-Destructiveness in Individuals With Schizophrenia

Revista Brasileira de Psiquiatria
PsychiatryMental Health
2017English

Effects of Continuing Oral Risperidone vs. Switching From Risperidone to Risperidone Long-Acting Injection on Cognitive Function in Stable Schizophrenia Patients: A Pilot Study

Frontiers in Psychiatry
PsychiatryMental Health
2018English

Smoking Among Individuals With Schizophrenia in Korea: Gender Differences

Archives of Psychiatric Nursing
Psychiatric Mental Health
2013English

Amygdala Hyperactivity at Rest in Paranoid Individuals With Schizophrenia

American Journal of Psychiatry
PsychiatryMental Health
2015English

Short Term Effectiveness of Haloperidol Versus Risperidone in First-Episode Schizophrenia

Proceedings of Singapore Healthcare
Medicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy